A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)

Clinical trial NCT05624281 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT05624281
Sponsor: Boehringer Ingelheim
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Lung Diseases, Interstitial (in Pediatric Populations)Childhood Interstitial Lung Disease (chILD)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.